IBDEI0TE ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13227,1,4,0)
 ;;=4^H40.51X4
 ;;^UTILITY(U,$J,358.3,13227,2)
 ;;=^5005891
 ;;^UTILITY(U,$J,358.3,13228,0)
 ;;=H40.63X0^^51^632^57
 ;;^UTILITY(U,$J,358.3,13228,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13228,1,3,0)
 ;;=3^GLU 2nd to Drugs,OU,Stage Unspec
 ;;^UTILITY(U,$J,358.3,13228,1,4,0)
 ;;=4^H40.63X0
 ;;^UTILITY(U,$J,358.3,13228,2)
 ;;=^5005914
 ;;^UTILITY(U,$J,358.3,13229,0)
 ;;=H40.63X1^^51^632^58
 ;;^UTILITY(U,$J,358.3,13229,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13229,1,3,0)
 ;;=3^GLU 2nd to Drugs,OU,MIld Stage
 ;;^UTILITY(U,$J,358.3,13229,1,4,0)
 ;;=4^H40.63X1
 ;;^UTILITY(U,$J,358.3,13229,2)
 ;;=^5005915
 ;;^UTILITY(U,$J,358.3,13230,0)
 ;;=H40.63X2^^51^632^59
 ;;^UTILITY(U,$J,358.3,13230,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13230,1,3,0)
 ;;=3^GLU 2nd to Drugs,OU,Moderate Stage
 ;;^UTILITY(U,$J,358.3,13230,1,4,0)
 ;;=4^H40.63X2
 ;;^UTILITY(U,$J,358.3,13230,2)
 ;;=^5005916
 ;;^UTILITY(U,$J,358.3,13231,0)
 ;;=H40.63X3^^51^632^60
 ;;^UTILITY(U,$J,358.3,13231,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13231,1,3,0)
 ;;=3^GLU 2nd to Drugs,OU,Severe Stage
 ;;^UTILITY(U,$J,358.3,13231,1,4,0)
 ;;=4^H40.63X3
 ;;^UTILITY(U,$J,358.3,13231,2)
 ;;=^5005917
 ;;^UTILITY(U,$J,358.3,13232,0)
 ;;=H40.63X4^^51^632^61
 ;;^UTILITY(U,$J,358.3,13232,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13232,1,3,0)
 ;;=3^GLU 2nd to Drugs,OU,Indeterminate Stage
 ;;^UTILITY(U,$J,358.3,13232,1,4,0)
 ;;=4^H40.63X4
 ;;^UTILITY(U,$J,358.3,13232,2)
 ;;=^5005918
 ;;^UTILITY(U,$J,358.3,13233,0)
 ;;=H40.62X0^^51^632^52
 ;;^UTILITY(U,$J,358.3,13233,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13233,1,3,0)
 ;;=3^GLU 2nd to Drugs,OS,Stage Unspec
 ;;^UTILITY(U,$J,358.3,13233,1,4,0)
 ;;=4^H40.62X0
 ;;^UTILITY(U,$J,358.3,13233,2)
 ;;=^5005910
 ;;^UTILITY(U,$J,358.3,13234,0)
 ;;=H40.62X1^^51^632^53
 ;;^UTILITY(U,$J,358.3,13234,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13234,1,3,0)
 ;;=3^GLU 2nd to Drugs,OS,Mild Stage
 ;;^UTILITY(U,$J,358.3,13234,1,4,0)
 ;;=4^H40.62X1
 ;;^UTILITY(U,$J,358.3,13234,2)
 ;;=^5005911
 ;;^UTILITY(U,$J,358.3,13235,0)
 ;;=H40.62X2^^51^632^54
 ;;^UTILITY(U,$J,358.3,13235,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13235,1,3,0)
 ;;=3^GLU 2nd to Drugs,OS,Moderate Stage
 ;;^UTILITY(U,$J,358.3,13235,1,4,0)
 ;;=4^H40.62X2
 ;;^UTILITY(U,$J,358.3,13235,2)
 ;;=^5005912
 ;;^UTILITY(U,$J,358.3,13236,0)
 ;;=H40.62X3^^51^632^55
 ;;^UTILITY(U,$J,358.3,13236,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13236,1,3,0)
 ;;=3^GLU 2nd to Drugs,OS,Severe Stage
 ;;^UTILITY(U,$J,358.3,13236,1,4,0)
 ;;=4^H40.62X3
 ;;^UTILITY(U,$J,358.3,13236,2)
 ;;=^5133510
 ;;^UTILITY(U,$J,358.3,13237,0)
 ;;=H40.62X4^^51^632^56
 ;;^UTILITY(U,$J,358.3,13237,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13237,1,3,0)
 ;;=3^GLU 2nd to Drugs,OS,Indeterminate Stage
 ;;^UTILITY(U,$J,358.3,13237,1,4,0)
 ;;=4^H40.62X4
 ;;^UTILITY(U,$J,358.3,13237,2)
 ;;=^5005913
 ;;^UTILITY(U,$J,358.3,13238,0)
 ;;=H40.61X0^^51^632^47
 ;;^UTILITY(U,$J,358.3,13238,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13238,1,3,0)
 ;;=3^GLU 2nd to Drugs,OD,Stage Unspec
 ;;^UTILITY(U,$J,358.3,13238,1,4,0)
 ;;=4^H40.61X0
 ;;^UTILITY(U,$J,358.3,13238,2)
 ;;=^5005906
 ;;^UTILITY(U,$J,358.3,13239,0)
 ;;=H40.61X1^^51^632^48
 ;;^UTILITY(U,$J,358.3,13239,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13239,1,3,0)
 ;;=3^GLU 2nd to Drugs,OD,Mild Stage
 ;;^UTILITY(U,$J,358.3,13239,1,4,0)
 ;;=4^H40.61X1
